NEW YORK (GenomeWeb) – NanoString Technologies said yesterday that it had closed a previously announced underwritten public offering of 3,450,000 shares of its common stock at a price of $16.75 per share.

RW Baird served as sole underwriter for the offering and exercised in full an additional option to purchase another 450,000 shares pursuant to NanoString's existing shelf registration statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.